Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Corvus Pharmaceuticals, Inc
Scientific Title
A Phase 1/1b, Open-Label, Multicenter, Repeat-Dose, Dose-Selection Study of CPI-444 as Single Agent and in Combination With Atezolizumab in Patients With Selected Incurable Cancers